Brazil Drug Distributor Sells 51% Stake To Hungary-Based Drug Maker
This article was originally published in PharmAsia News
Next Pharma, a Brazil drug distributor, sold a 51% stake for an undisclosed amount to Hungary drug maker Richter, which also has an option to buy the remainder of the privately held company.
You may also be interested in...
Takeda launches blockbuster gastrointestinal drug vedolizumab in India, stepping up the tempo on the back of the local base provided by its acquisition of Shire. More expansion in the country appears to be in store for the Japanese firm.
The US FDA’s Circulatory System Devices advisory panel will meet on 27 October to discuss the review of the premarket approval application of Neovasc’s Reducer device, which is intended to treat angina. See what Neovasc’s CEO Fred Colen said about it here.
Join us for a quick audio roundup of five useful things to know from Scrip's recent coverage of the global biopharmaceutical industry.